Baidu
map

JAMA:短信提醒可提高低收入儿童和青少年的流感疫苗接种率

2012-05-19 EurekAlert EurekAlert

据4月25日刊《美国医学会杂志》上的一项研究披露,与常规的医疗方式相比,一种通过给家长发送与教育有关的讯息短信的干预方法可在一个按照惯例难以联系到的、低收入的、城市少数族裔的儿童及青少年人群中增加流感疫苗接种的覆盖率,尽管总体的覆盖率仍然低下。 纽约市哥伦比亚大学的Melissa S. Stockwell, M.D., M.P.H.及其同事评估了以低收入、城市中的家长为目标的,宣传在儿童和青少年

据4月25日刊《美国医学会杂志》上的一项研究披露,与常规的医疗方式相比,一种通过给家长发送与教育有关的讯息短信的干预方法可在一个按照惯例难以联系到的、低收入的、城市少数族裔的儿童及青少年人群中增加流感疫苗接种的覆盖率,尽管总体的覆盖率仍然低下。

纽约市哥伦比亚大学的Melissa S. Stockwell, M.D., M.P.H.及其同事评估了以低收入、城市中的家长为目标的,宣传在儿童和青少年中接种流感疫苗的短信的效果。该随机对照的试验包括了9,213名年龄在6个月至18岁的儿童和青少年,他们于2010-2011流感季节在4家美国的以社区为基础的诊所中接受了治疗。在这9,213名儿童和青少年中,有7,574人在该干预开始之日前没有接受过流感的疫苗接种,他们被纳入首要的分析之中。被分到干预组的孩子的家长每周会收到多至5个免疫注册相关的短信,这些短信提供了教育性的资讯及有关周六诊所的说明。

在这一研究中的儿童和青少年主要为少数族裔,他们中88%的人具有公共保险,有58%的人来自说西班牙语的家庭。截至2011年3月31日,与常规治疗组(39.9%)相比,干预组中的儿童和青少年有着较高的接种了流感疫苗的比例(43.6%)。到这一日期为止,在所有接种了疫苗的儿童和青少年中,在干预组中,有93.9%的人是在周六诊所之外接种疫苗的,而在常规治疗组中,这一比例为97.2%。

在基于组群的秋季审查日时,接种了流感疫苗的比例在干预组中为27.1% vs.常规治疗组中为22.8%。

文章的作者写道:“用短信来增加疫苗接种的覆盖率有着众多的优点。它可以联系到庞大的人群,而像流感疫苗这样的建议为大多数人进行接种的疫苗,接种率只要有小幅的增加都可产生数目庞大的受到保护的个人。它也可能很划算。这一系统一旦设立,唯一的可变成本就是发送短信,而即便使用的是商用平台,其每则短信的成本也常常只需几分钱。因此,取决于人口的规模,即使预先摊销并监控成本,基于每一个人的发送短信的成本还是便宜的。”(生物谷:Bioon.com)

doi:10.1038/nbt.2149
PMC:
PMID:

Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population

Melissa S. Stockwell, MD, MPH; Elyse Olshen Kharbanda, MD, MPH; Raquel Andres Martinez, PhD; Celibell Y. Vargas, MD; David K. Vawdrey, PhD; Stewin Camargo, BS

Context Influenza infection results in substantial costs, morbidity, and mortality. Vaccination against influenza is particularly important in children and adolescents who are a significant source of transmission to other high-risk populations, yet pediatric and adolescent vaccine coverage remains low. Traditional vaccine reminders have had a limited effect on low-income populations; however, text messaging is a novel, scalable approach to promote influenza vaccination.

Objective To evaluate targeted text message reminders for low-income, urban parents to promote receipt of influenza vaccination among children and adolescents.

Design, Setting, and Participants Randomized controlled trial of 9213 children and adolescents aged 6 months to 18 years receiving care at 4 community-based clinics in the United States during the 2010-2011 influenza season. Of the 9213 children and adolescents, 7574 had not received influenza vaccine prior to the intervention start date and were included in the primary analysis.

Intervention Parents of children assigned to the intervention received up to 5 weekly immunization registry–linked text messages providing educational information and instructions regarding Saturday clinics. Both the intervention and usual care groups received the usual care, an automated telephone reminder, and access to informational flyers posted at the study sites.

Main Outcome Measures Receipt of an influenza vaccine dose recorded in the immunization registry via an electronic health record by March 31, 2011. Receipt was secondarily assessed at an earlier fall review date prior to typical widespread influenza activity.

Results Study children and adolescents were primarily minority, 88% were publicly insured, and 58% were from Spanish-speaking families. As of March 31, 2011, a higher proportion of children and adolescents in the intervention group (43.6%; n = 1653) compared with the usual care group (39.9%; n = 1509) had received influenza vaccine (difference, 3.7% [95% CI, 1.5%-5.9%]; relative rate ratio [RRR], 1.09 [95% CI, 1.04-1.15]; P = .001). At the fall review date, 27.1% (n = 1026) of the intervention group compared with 22.8% (n = 864) of the usual care group had received influenza vaccine (difference, 4.3% [95% CI, 2.3%-6.3%]; RRR, 1.19 [95% CI, 1.10-1.28]; P < .001).

Conclusions Among children and adolescents in a low-income, urban population, a text messaging intervention compared with usual care was associated with an increased rate of influenza vaccination. However, the overall influenza vaccination rate remained low.

Trial Registration clinicaltrials.gov Identifier: NCT01146912

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078647, encodeId=16fe20e8647ec, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Jun 08 03:15:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937424, encodeId=9764193e42427, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Mar 13 04:15:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953970, encodeId=997619539e088, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Thu Apr 18 02:15:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019508, encodeId=8d9520195082d, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Feb 13 10:15:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257804, encodeId=290d125e80443, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-06-08 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078647, encodeId=16fe20e8647ec, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Jun 08 03:15:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937424, encodeId=9764193e42427, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Mar 13 04:15:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953970, encodeId=997619539e088, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Thu Apr 18 02:15:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019508, encodeId=8d9520195082d, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Feb 13 10:15:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257804, encodeId=290d125e80443, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078647, encodeId=16fe20e8647ec, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Jun 08 03:15:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937424, encodeId=9764193e42427, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Mar 13 04:15:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953970, encodeId=997619539e088, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Thu Apr 18 02:15:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019508, encodeId=8d9520195082d, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Feb 13 10:15:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257804, encodeId=290d125e80443, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2013-04-18 Homburg
  4. [GetPortalCommentsPageByObjectIdResponse(id=2078647, encodeId=16fe20e8647ec, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Jun 08 03:15:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937424, encodeId=9764193e42427, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Mar 13 04:15:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953970, encodeId=997619539e088, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Thu Apr 18 02:15:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019508, encodeId=8d9520195082d, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Feb 13 10:15:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257804, encodeId=290d125e80443, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2078647, encodeId=16fe20e8647ec, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Jun 08 03:15:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937424, encodeId=9764193e42427, content=<a href='/topic/show?id=b3252822854' target=_blank style='color:#2F92EE;'>#儿童和青少年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28228, encryptionId=b3252822854, topicName=儿童和青少年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Mar 13 04:15:00 CST 2013, time=2013-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953970, encodeId=997619539e088, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Thu Apr 18 02:15:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2019508, encodeId=8d9520195082d, content=<a href='/topic/show?id=dbba65336b1' target=_blank style='color:#2F92EE;'>#流感疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65336, encryptionId=dbba65336b1, topicName=流感疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Feb 13 10:15:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257804, encodeId=290d125e80443, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]

相关资讯

Fitoterapia:剧毒植物钩吻的免疫抑制活性成分

钩吻 近日,国际著名杂志Fitoterapia在线刊登了西双版纳热带植物园研究者的最新研究成果“Gelsemium Alkaloids,Immunosuppressive Agents from Gelsemium elegans,”,文章中,研究者发现了剧毒植物钩吻的免疫抑制活性成分。 钩吻(Gelsemium elegans)又名断肠草,是著名的剧毒植物,每年均有因误食而中毒死亡的悲剧发生

J. Immunol:日开发新方法可判断多发性硬化症疗效

近日,日本大阪大学和理化学研究所的研究小组在新一期《免疫学期刊》(The Journal of Immunology)上报告说,他们开发出一种血液检测方法,能够提前判断常用治疗药物培他干扰素对多发性硬化症患者是否有效。 多发性硬化症是一种中枢神经系统疾病,患者自身免疫细胞会错误攻击神经元髓鞘,造成患者出现视觉障碍、肌肉无力等症状。通常对多发性硬化症患者都采用注射培他干扰素进行治疗。&nb

Lancet:免疫接种可减少麻疹致死病例

4月24日,世界卫生组织与美国疾病控制和预防中心、联合国儿童基金会联合宣布一项旨在消除麻疹致死病例以及先天性风疹的全球计划。 最新一期英国《柳叶刀》(Lancet)杂志刊登报告称,免疫接种可减少麻疹致死病例。该研究显示,随着免疫接种的不断推广,全球因麻疹致死的人数从2000年的约53.53万下降到了2010年的13.93万,减少了74%。 这一全球计划希望通过五大措施实现以下目标:2015年将

Immuni:美阐明朗格汉斯细胞维持免疫自稳的机制

日前,美研究人员在线发表了题为《Human Epidermal Langerhans Cells Maintain Immune Homeostasis in Skin by Activating Skin Resident Regulatory T Cells》研究论文,阐明了朗格汉斯细胞是如何维持皮肤组织的免疫自稳。该研究论文发表在国际期刊Immunity上。 正常成年人的皮肤中常驻着100

PNAS:邵峰等肺炎军团菌逃避宿主AIM2炎症小体天然免疫研究获进展

近日,国际著名杂志PNAS在线刊登了北京生命科学研究所邵峰博士实验室的最新研究成果“Preventing bacterial DNA release and absent in melanoma 2 inflammasome activation by a Legionella effector functioning in membrane trafficking,”,该篇文章首次报道了肺炎军团

J Immun:过度卫生的生活方式或影响新生儿免疫系统的发育

MedSci评注:     近来一系列研究均表明,在新生儿免疫建立期(一般认为在出生后6个月左右),让免疫系统“适应”环境,训练免疫系统接触环境中不良因素,从而产生免疫耐受,减少今后的过敏反应。这些环境中的因素包括土壤中的微生素群落,空气土壤中的真菌,花粉,尘螨等,一旦早期建立起对这些物质的免疫耐受,可以防止青少年,甚至成年的众多自身免疫性疾病,过敏性疾病。因此,中

Baidu
map
Baidu
map
Baidu
map